摘要
癌症已经是全球范围内的一个主要健康问题,因此基于当前研究成果更加有效地治疗策略不断地被提出。慢性的、无法检测的炎症被广泛地认为能够引发癌症。先天性的免疫系统作为第一道防线,其中炎症体是必需的以维持炎性因子和抗炎因子间的微妙平衡,以保证产生一个合适的免疫反应且不伤害到宿主。研究已经揭示出一个显著的,但是矛盾的宿主免疫反应和肿瘤发生间的联系。确实,由危险信号激活的多个蛋白复合免疫炎症体在癌症发生和发展过程中似乎起着多种和有时是矛盾的、抑制的或者刺激的作用,并伴有一个显著的环境依赖性。多效性的炎症体可能作用于细胞自治水平并通过炎症突触类型的程序性细胞凋亡来消除恶性细胞,但是相反的,也有可能产生有利于肿瘤细胞生长和它们的微环境营养的因子。此外,依靠天冬氨酸-1激活的炎性体能够引发无菌炎症,并且提供致癌因素,所有抗原提呈细胞能够引出抗肿瘤免疫反应。明确的说,环境特异影响肿瘤发生的炎症体代表了一个新的研究领域,具有潜在作用以进出一个有前景的新颖的靶标用于癌症治疗。
关键词: 癌症,天冬氨酸-1,炎症,炎症体,促炎性细胞因子,细胞死亡。
Current Drug Targets
Title:Inflammasome, Inflammation and Cancer: An Interrelated Pathobiological Triad
Volume: 16 Issue: 3
Author(s): Gyorgyi Muzes and Ferenc Sipos
Affiliation:
关键词: 癌症,天冬氨酸-1,炎症,炎症体,促炎性细胞因子,细胞死亡。
摘要: Cancer represents a major health problem worldwide, therefore on the basis of current research results constantly more effective therapeutic strategies are expected. Chronic, unchecked inflammation has widely been suggested to trigger carcinogenesis. The innate immune system ensures a first line host defense in which the inflammasome is essential maintaining a delicate balance betweeen pro- and anti-inflammatory signals in order to generate an appropriate immune response without harming the host. Studies have revealed a remarkable, but contradictory link of host inflammatory responses to tumorigenesis. Indeed, activation of the multiprotein complex inflammasome by danger signals seems to play diverse and sometimes conflicting, suppressive or stimulatory role in cancer development and progression with a significant context-dependency. The pleitropic inflammasomes may act at cellautonomous level to eliminate malignant cells via the programmed cell death type of inflammatory pyroptosis, but on the contrary, may favor the production of gowth and trophic factors for tumor cells and their microenvironment. Further, upon caspase-1 activation the inflammasome can provoke sterile inflammation, and thus facilitate carcinogenesis, though in antigen-presenting cells it can elicit anti-tumor immune responses. Clarifying the exact, context-specific impact of inflammasomes on tumorigenesis represents a new research area with the potential to introduce promising novel targets for cancer therapeutics.
Export Options
About this article
Cite this article as:
Gyorgyi Muzes and Ferenc Sipos , Inflammasome, Inflammation and Cancer: An Interrelated Pathobiological Triad, Current Drug Targets 2015; 16 (3) . https://dx.doi.org/10.2174/1389450115666141229154157
DOI https://dx.doi.org/10.2174/1389450115666141229154157 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Angiotensin II Receptor Blocker: Possibility of Antitumor Agent for Prostate Cancer
Mini-Reviews in Medicinal Chemistry Strategies for the Biological Evaluation of Gold Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Anti PD-1 and PDL-1 Immunotherapy in the Treatment of Advanced Non- Small Cell Lung Cancer (NSCLC): A Review on Toxicity Profile and its Management
Current Drug Safety Overview of Angiogenesis and the use of Bevacizumab in Patients with Malignant Gliomas
Current Signal Transduction Therapy MicroRNA as Regulators of Cancer Stem Cells and Chemoresistance in Colorectal Cancer
Current Cancer Drug Targets Anti-Inflammatory Effects of Triterpenoids; Naturally Occurring and Synthetic Agents
Mini-Reviews in Organic Chemistry Repurposing Chloroquine Analogs as an Adjuvant Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Genome-wide Differential-based Analysis of the Relationship between DNA Methylation and Gene Expression in Cancer
Current Bioinformatics The Role of PET/CT and SPECT/CT in Oncology Drug Development
Current Molecular Imaging (Discontinued) Cell Cycle and Energy Metabolism in Tumor Cells: Strategies for Drug Therapy
Recent Patents on Anti-Cancer Drug Discovery The Role of Integrins in Glioma Biology and Anti-Glioma Therapies
Current Pharmaceutical Design Use of Anticancer Platinum Compounds in Combination Therapies and Challenges in Drug Delivery
Current Medicinal Chemistry New Adamantane Derivatives with Sigma Affinity and Antiproliferative Activity
Medicinal Chemistry The Role of Chronic Periodontitis in Prevention and Treatment of Head and Neck Cancers
Current Cancer Therapy Reviews Role of PARP Inhibitors in Cancer Biology and Therapy
Current Medicinal Chemistry ADAM Proteins- Therapeutic Potential in Cancer
Current Cancer Drug Targets The Renin Angiotensin System in the Regulation of Angiogenesis
Current Pharmaceutical Design Clinical Proteomics in Application to Predictive Diagnostics and Personalized Treatment of Diabetic Patients
Current Proteomics Gene Therapy Using IL-12 Family Members in Infection, Auto-Immunity, and Cancer
Current Gene Therapy Polyketide Natural Products, Acetogenins from Graviola (Annona muricata L), its Biochemical, Cytotoxic Activity and Various Analyses Through Computational and Bio-Programming Methods
Current Pharmaceutical Design